Mahamaya Lifesciences Ltd

Initial public offer of up to 61,78,800* equity shares of face value of Rs. 10/- each (Equity sSares) of Mahamaya Lifesciences Limited (MLL or the Company) for cash at price of Rs. [] per equity share (including a share premium of [] per equity share) (the Offer Price), aggregating up to Rs. [] (the Offer), comprising a fresh offer of upto 56,38,800 equity shares aggregating to Rs. [] (the Fresh Offer) and an offer for sale of upto 540,000 equity shares (the Offered Shares) of face value of Rs. 10/- each by []; (the Selling Shareholder) aggregating to [] equity shares by the selling shareholders (Offer for Sale) aggregating to Rs. [] crores, out of which [] equity shares of face value of Rs. 10/- each, at an offer price of Rs. [] per equity share for cash, aggregating Rs. [] crores will be reserved for subscription by the market maker to the offer (the Market Maker Reservation Portion). The offer less market maker reservation portion i.e. net offer of [] equity shares of face value of Rs. 10/- each, at an offer price of Rs. [] per equity share for cash, aggregating up to Rs. [] crores is hereinafter referred to as the Net Offer. The offer and net offer will constitute [] % and [*] % respectively of the post-offer paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.